As of 2024-12-14, the Relative Valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (51.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.21 USD, the upside of Arcturus Therapeutics Holdings Inc based on Relative Valuation is -401.0%.
The range of the Relative Valuation is (42.78) - (44.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 34.4x | 25.8x |
| Forward P/E multiples | 18.5x - 19.4x | 19.0x |
| Fair Price | (42.78) - (44.86) | (51.80) |
| Upside | -348.6% - -360.7% | -401.0% |
| Date | P/E |
| 2024-12-13 | -7.44 |
| 2024-12-12 | -7.59 |
| 2024-12-11 | -7.76 |
| 2024-12-10 | -7.94 |
| 2024-12-09 | -8.14 |
| 2024-12-06 | -8.26 |
| 2024-12-05 | -7.72 |
| 2024-12-04 | -7.45 |
| 2024-12-03 | -7.74 |
| 2024-12-02 | -8.06 |
| 2024-11-29 | -7.93 |
| 2024-11-27 | -7.57 |
| 2024-11-26 | -7.32 |
| 2024-11-25 | -7.60 |
| 2024-11-22 | -7.31 |
| 2024-11-21 | -7.38 |
| 2024-11-20 | -6.99 |
| 2024-11-19 | -7.81 |
| 2024-11-18 | -7.04 |
| 2024-11-15 | -6.93 |
| 2024-11-14 | -7.93 |
| 2024-11-13 | -8.29 |
| 2024-11-12 | -8.47 |
| 2024-11-11 | -8.81 |
| 2024-11-08 | -8.49 |
| 2024-11-07 | -8.10 |
| 2024-11-06 | -7.93 |
| 2024-11-05 | -7.94 |
| 2024-11-04 | -7.71 |
| 2024-11-01 | -7.78 |
| 2024-10-31 | -7.67 |
| 2024-10-30 | -7.95 |
| 2024-10-29 | -8.27 |
| 2024-10-28 | -8.46 |
| 2024-10-25 | -8.19 |
| 2024-10-24 | -8.22 |
| 2024-10-23 | -8.65 |
| 2024-10-22 | -8.56 |
| 2024-10-21 | -9.03 |
| 2024-10-18 | -9.15 |
| 2024-10-17 | -8.91 |
| 2024-10-16 | -8.92 |
| 2024-10-15 | -9.07 |
| 2024-10-14 | -9.05 |
| 2024-10-11 | -9.28 |
| 2024-10-10 | -8.91 |
| 2024-10-09 | -9.47 |
| 2024-10-08 | -9.72 |
| 2024-10-07 | -10.32 |
| 2024-10-04 | -10.33 |